![Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0079610711000812-gr3.jpg)
Two incretin hormones GLP-1 and GIP: Comparison of their actions in insulin secretion and β cell preservation - ScienceDirect
![Intracellular actions of GIP and GLP-1 on the-cell. Several cellular... | Download Scientific Diagram Intracellular actions of GIP and GLP-1 on the-cell. Several cellular... | Download Scientific Diagram](https://www.researchgate.net/profile/Michael-Nauck/publication/43351718/figure/fig3/AS:667650296385545@1536191643322/Intracellular-actions-of-GIP-and-GLP-1-on-the-cell-Several-cellular-functions-are.png)
Intracellular actions of GIP and GLP-1 on the-cell. Several cellular... | Download Scientific Diagram
![Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ... Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ...](https://www.mdpi.com/biology/biology-11-00288/article_deploy/html/images/biology-11-00288-g001.png)
Biology | Free Full-Text | Gastrointestinal Incretins—Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide-1 (GLP-1) beyond Pleiotropic Physiological Effects Are Involved in Pathophysiology of Atherosclerosis and Coronary ...
![Effects of GLP-1 (blue arrows), glucagon (red arrows) and GIP (green... | Download Scientific Diagram Effects of GLP-1 (blue arrows), glucagon (red arrows) and GIP (green... | Download Scientific Diagram](https://www.researchgate.net/publication/327758042/figure/fig1/AS:705975497531393@1545329083967/Effects-of-GLP-1-blue-arrows-glucagon-red-arrows-and-GIP-green-arrows-on-energy.png)
Effects of GLP-1 (blue arrows), glucagon (red arrows) and GIP (green... | Download Scientific Diagram
![Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-022-01604-7/MediaObjects/12933_2022_1604_Fig1_HTML.png)
Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology | Full Text
![GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/17f97155-8c0a-4d47-98b1-56ef9893b303/jdi_22_f2.gif)
GIP and GLP‐1, the two incretin hormones: Similarities and differences - Seino - 2010 - Journal of Diabetes Investigation - Wiley Online Library
![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/cef7eacf-1f50-4531-9c5d-b839fae38f91/dom14496-fig-0001-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library](https://dom-pubs.onlinelibrary.wiley.com/cms/asset/414ba3e0-5948-4dd5-a9ba-672073b1496d/dom14496-fig-0002-m.jpg)
The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: A pathophysiological update - Nauck - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
![Gksz Ipari terület Általános Gip-1 Településgazdálkodási Gip-2 K ü l ö n l e g e s t e r ü l e t Sportterület Ksp-1. Ksp-2 Temető - PDF Ingyenes letöltés Gksz Ipari terület Általános Gip-1 Településgazdálkodási Gip-2 K ü l ö n l e g e s t e r ü l e t Sportterület Ksp-1. Ksp-2 Temető - PDF Ingyenes letöltés](https://docplayer.hu/docs-images/43/1622065/images/page_1.jpg)
Gksz Ipari terület Általános Gip-1 Településgazdálkodási Gip-2 K ü l ö n l e g e s t e r ü l e t Sportterület Ksp-1. Ksp-2 Temető - PDF Ingyenes letöltés
![Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/852ca66060ffdba66beb14e27e19fbc2a63a970f/3-Figure2-1.png)
Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation. | Semantic Scholar
![Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes – touchENDOCRINOLOGY Tirzepatide: A Novel, Once-weekly Dual GIP and GLP-1 Receptor Agonist for the Treatment of Type 2 Diabetes – touchENDOCRINOLOGY](https://www.touchendocrinology.com/wp-content/uploads/sites/5/2022/06/Fig-1.png)